argenx SE Investor Day Presentation Deck slide image

argenx SE Investor Day Presentation Deck

Efgartigimod: Differentiation of our Anti-FcRn Fragment Hans de Haard Chief Scientific Officer and Co-Founder argenx
View entire presentation